LINEE GUIDA

25. Morita T, Chinone Y, Ikenaga M, Miyoshi M, Nakaho T, Nishitateno K, et al. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage. 2005;30(4):320-8.

26. Parra Palacio S, Giraldo Hoyos CE, Arias Rodríguez C, Mejía Arrieta D, Vargas Gómez JJ, Krikorian A. Palliative sedation in advanced cancer patients hospitalized in a specialized palliative care unit. Supportive Care in Cancer. 2018;26(9):3173-80

27. Porzio G, Aielli F, Verna L, Micolucci G, Aloisi P, Ficorella C. Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study. Supportive Care in Cancer. 2010;18(1):77-81.

28. Rosengarten OS, Lamed Y, Zisling T, Feigin A, Jacobs JM. Palliative sedation at home. Journal of Palliative Care. 2009;25(1):5-11

29. Setla J, Pasniciuc SV. Home Palliative Sedation Using Phenobarbital Suppositories: Time to Death, Patient Characteristics, and Administration Protocol. The American journal of hospice & palliative care. 2019;36(10):871-6.

30. Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. Journal of pain and symptom management. 1999;17(5):363-8.

31. Won YW, Chun HS, Seo M, Kim RB, Kim JH, Kang JH. Clinical Patterns of Continuous and Intermittent Palliative Sedation in Patients With Terminal Cancer: A Descriptive, Observational Study. Journal of Pain and Symptom Management. 2019;58(1):65-71

Allegato 3

VALUTAZIONE DEL RISCHIO DI BIAS DEGLI STUDI CON GRUPPO DI CONFRONTO (COCHRANE TOOL)